# Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy

> **NCT00986440** · PHASE2 · TERMINATED · sponsor: **Daiichi Sankyo** · enrollment: 84 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** CS-7017
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00986440
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07-31
- **Primary completion:** 2012-10-29
- **Final completion:** 2012-10-29
- **Target enrollment:** 84 (ACTUAL)
- **Why stopped:** Due to changes to the standard of care within the proposed market for CS-7017.
- **Last updated:** 2020-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00986440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00986440, "Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00986440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*